Where should research start in solving Alzheimer's? That's a tricky question to answer. What exactly are researchers looking for when trying to solve the Alzheimer’s puzzle? “It depends on the researcher,” says Kevin Hascup, PhD. “Really, the tried and true biomarkers are three — amyloid, tau and neurofilament light chain, or what is known as A/T/N.” A biomarker (molecules in blood, body fluid, and tissue) helps with understanding the changes that occur with age and disease onset. Each of the three A/T/N biomarkers progress in its own way in aging and with dementia. But no matter which

Aida Adlimoghaddam, PhD, joins the Smith Alzheimer's Center in 2023 as an Assistant Professor. Most recently, she was the Senior Research Associate and Clinical Scientist at St. Boniface Hospital Research Centre in Winnipeg, Canada. What sparked your interest in research? As an undergraduate student, I developed a deep passion for biological sciences and discovered the vast array of research opportunities within the field. However, what truly fueled my interest in Alzheimer's research was a personal connection. My grandmother was diagnosed with Alzheimer's disease and endured several years of